August 2010

Rheonix Receives Additional $233K Award from National Institutes of Health

Ithaca, N.Y. — August 17, 2010 — Rheonix, Inc. today announced that the National Institutes of Health has added a $233,044 supplement to its previously awarded Point-of-Care Partnership grant. The POC Partnership grant is funded to develop a fully automated molecular diagnostic for the detection of multiple sexually transmitted infections (STI). The supplement, awarded under the American Recovery and Reinvestment Act (ARRA) of 2009, was added to expand the scope… Read More »
Rheonix receives FDA Emergency Use Authorization for Automated COVID-19 Test.
Learn More